1. Home
  2. MSTR vs EW Comparison

MSTR vs EW Comparison

Compare MSTR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroStrategy Incorporated

MSTR

MicroStrategy Incorporated

N/A

Current Price

$114.93

Market Cap

54.5B

Sector

Technology

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$105.38

Market Cap

52.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSTR
EW
Founded
1989
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.5B
52.3B
IPO Year
1998
1999

Fundamental Metrics

Financial Performance
Metric
MSTR
EW
Price
$114.93
$105.38
Analyst Decision
Strong Buy
Buy
Analyst Count
16
30
Target Price
★ $233.27
$113.24
AVG Volume (30 Days)
★ 13.8M
4.5M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.61
Revenue
$463,456,000.00
★ $6,067,600,000.00
Revenue This Year
$4.82
$12.23
Revenue Next Year
$3.12
$9.84
P/E Ratio
★ N/A
$65.80
Revenue Growth
N/A
★ 11.55
52 Week Low
$81.81
$74.66
52 Week High
$213.83
$105.96

Technical Indicators

Market Signals
Indicator
MSTR
EW
Relative Strength Index (RSI) 33.68 76.77
Support Level $88.18 $82.21
Resistance Level $149.70 N/A
Average True Range (ATR) 7.52 3.29
MACD -2.42 1.28
Stochastic Oscillator 9.21 91.88

Price Performance

Historical Comparison
MSTR
EW

About MSTR MicroStrategy Incorporated

Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: